{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:12:23Z","timestamp":1787314343994,"version":"build-2736575974"},"reference-count":138,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.idc.2023.03.005","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T08:09:48Z","timestamp":1683014988000},"page":"617-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation"],"prefix":"10.1016","volume":"37","author":[{"given":"Paul A.","family":"Trubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan M.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3181\/00379727-141-36764","article-title":"Studies of morphology and immunofluorescence of Pneumocystis carinii","volume":"141","author":"Kim","year":"1972","journal-title":"Proc Soc Exp Biol Med"},{"issue":"51","key":"10.1016\/j.idc.2023.03.005_bib2","doi-asserted-by":"crossref","first-page":"40628","DOI":"10.1074\/jbc.M002103200","article-title":"Cell Wall Assembly by Pneumocystis carinii: Evidence for a unique Gsc-1 Subunit Mediating Beta-1,3-Glucan Deposition","volume":"275","author":"Kottom","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"11","key":"10.1016\/j.idc.2023.03.005_bib3","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1128\/AAC.38.11.2534","article-title":"Phytosterols are present in Pneumocystis carinii","volume":"38","author":"Furlong","year":"1994","journal-title":"Antimicrobial Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/CMR.00013-12","article-title":"Colonization by Pneumocystis jirovecii and its role in disease","volume":"25","author":"Morris","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4049\/jimmunol.177.1.459","article-title":"Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism","volume":"177","author":"Carmona","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"27","key":"10.1016\/j.idc.2023.03.005_bib6","doi-asserted-by":"crossref","first-page":"25001","DOI":"10.1074\/jbc.M301426200","article-title":"Pneumocystis carinii cell wall \u03b2-glucans initiate macrophage inflammatory responses through NF-\u03baB activation","volume":"278","author":"Lebron","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1550-7408.2003.tb00667.x","article-title":"Pneumocystis carinii: Cell wall \u03b2-glucan-mediated pulmonary inflammation","volume":"50","author":"Limper","year":"2003","journal-title":"J\u00a0Eukaryot Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib8","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1086\/315487","article-title":"Murine CD4+ T lymphocyte subsets and host defense against Pneumocystis carinii","volume":"181","author":"Shellito","year":"2000","journal-title":"JID (J Infect Dis)"},{"issue":"11","key":"10.1016\/j.idc.2023.03.005_bib9","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1128\/IAI.00519-16","article-title":"The life cycle stages of Pneumocystis murina have opposing effects on the immune response to this opportunistic fungal pathogen","volume":"84","author":"Evans","year":"2016","journal-title":"Infect Immun"},{"issue":"6322","key":"10.1016\/j.idc.2023.03.005_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/351155a0","article-title":"Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor","volume":"351","author":"Ezekowitz","year":"1991","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.idc.2023.03.005_bib11","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.20030932","article-title":"Alveolar macrophage\u2013mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the dectin-1 \u03b2-glucan receptor","volume":"198","author":"Steele","year":"2003","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4049\/jimmunol.1200861","article-title":"Memory CD4+ T\u00a0cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina","volume":"190","author":"Kelly","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4049\/jimmunol.1403162","article-title":"Eosinophils contribute to early clearance of Pneumocystis murina infection","volume":"195","author":"Eddens","year":"2015","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.idc.2023.03.005_bib14","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1128\/IAI.73.11.7450-7457.2005","article-title":"In\u00a0vitro effector activity of Pneumocystis murina-specific T-cytotoxic-1 CD8+ T\u00a0cells: role of granulocyte-macrophage colony-stimulating factor","volume":"73","author":"McAllister","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00939-16","article-title":"Differential macrophage polarization from pneumocystis in immunocompetent and immunosuppressed hosts: potential adjunctive therapy during pneumonia","volume":"85","author":"Nandakumar","year":"2017","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.idc.2023.03.005_bib16","article-title":"Immune response in pneumocystis infections according to the host immune system status","volume":"7","author":"Charpentier","year":"2021","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"5","key":"10.1016\/j.idc.2023.03.005_bib17","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1172\/JCI114621","article-title":"A\u00a0new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes","volume":"85","author":"Shellito","year":"1990","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199001183220304","article-title":"The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1","volume":"322","author":"Phair","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib19","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.171.3.1423","article-title":"Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P. carinii-specific antibody","volume":"171","author":"Lund","year":"2003","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1016\/j.idc.2023.03.005_bib20","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.155.7.3525","article-title":"CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice","volume":"155","author":"Wiley","year":"1995","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib21","doi-asserted-by":"crossref","first-page":"L291","DOI":"10.1152\/ajplung.00210.2018","article-title":"IL-10-producing B cells regulate Th1\/Th17-cell immune responses in Pneumocystis pneumonia","volume":"316","author":"Rong","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0039-3399559","article-title":"Pneumocystis jiroveci","volume":"41","author":"Fishman","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/319340","article-title":"Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants","volume":"32","author":"Vargas","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1542\/peds.61.1.35","article-title":"Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children","volume":"61","author":"Pifer","year":"1978","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.idc.2023.03.005_bib25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/mmy\/myaa107","article-title":"The shift from pulmonary colonization to Pneumocystis pneumonia","volume":"59","author":"Le Gal","year":"2021","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1286-4579(01)01514-3","article-title":"Update on the epidemiology and transmission of Pneumocystis carinii","volume":"4","author":"Morris","year":"2002","journal-title":"Microbes Infect"},{"issue":"6\u20137","key":"10.1016\/j.idc.2023.03.005_bib27","first-page":"599","article-title":"Transmission of Pneumocystis infection in humans","volume":"28","author":"Chab\u00e9","year":"2012","journal-title":"M-S (Med Sci): M\u00e9d\/Sci"},{"issue":"11","key":"10.1016\/j.idc.2023.03.005_bib28","doi-asserted-by":"crossref","first-page":"e1003025","DOI":"10.1371\/journal.ppat.1003025","article-title":"Pneumocystis: where does it live?","volume":"8","author":"Gigliotti","year":"2012","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3201\/eid0901.020141","article-title":"Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study","volume":"9","author":"Manoloff","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2023.03.005_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00002030-199903110-00020","article-title":"Pneumocystosis versus pulmonary Pneumocystis carinii colonization in HIV-negative and HIV-positive patients","volume":"13","author":"Nevez","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2023.03.005_bib31","series-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy","year":"1996"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"Limper","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.idc.2023.03.005_bib33","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2023.03.005_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1513\/pats.200602-015MS","article-title":"An official ATS workshop summary: recent advances and future directions in pneumocystis pneumonia (PCP)","volume":"3","author":"Huang","year":"2006","journal-title":"Proc Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3201\/eid1903.121151","article-title":"Increasing Pneumocystis pneumonia, England, UK, 2000-2010","volume":"19","author":"Maini","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"s4","key":"10.1016\/j.idc.2023.03.005_bib36","article-title":"Pneumocystis pneumonia in solid organ transplant recipients","volume":"9","author":"Martin","year":"2009","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1399-3062.2011.00645.x","article-title":"Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis","volume":"13","author":"de Boer","year":"2011","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/ajt.12947","article-title":"Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis","volume":"15","author":"Iriart","year":"2015","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.idc.2023.03.005_bib39","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/cid\/cis217","article-title":"Outbreaks of Pneumocystis pneumonia in 2 renal transplant centers linked to a single strain of Pneumocystis: implications for transmission and virulence","volume":"54","author":"Sassi","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-3062.2009.00447.x","article-title":"Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients","volume":"12","author":"Gianella","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2023.03.005_bib41","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/cid\/ciz901","article-title":"Pneumocystis infection outbreaks in organ transplantation units in France: a nation-wide survey","volume":"70","author":"Le Gal","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2016.01.018","article-title":"Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control","volume":"93","author":"Yiannakis","year":"2016","journal-title":"J\u00a0Hosp Infect"},{"issue":"4","key":"10.1016\/j.idc.2023.03.005_bib43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/cid\/ciab474","article-title":"Genetic and epidemiologic analyses of an outbreak of pneumocystis jirovecii pneumonia among kidney transplant recipients in the United States","volume":"74","author":"Azar","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2023.03.005_bib44","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cix495","article-title":"Outbreak of Pneumocystis jirovecii infection among heart transplant recipients: molecular investigation and management of an interhuman transmission","volume":"65","author":"Vindrios","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2023.03.005_bib45","first-page":"673","article-title":"Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review","volume":"49","author":"de Boer","year":"2011","journal-title":"Med Mycol"},{"issue":"7","key":"10.1016\/j.idc.2023.03.005_bib46","doi-asserted-by":"crossref","first-page":"e1456","DOI":"10.1093\/cid\/ciaa1611","article-title":"Identification of predictive markers and outcomes of late-onset pneumocystis jirovecii pneumonia in kidney transplant recipients","volume":"73","author":"Kaminski","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2023.03.005_bib47","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/ciy682","article-title":"A\u00a0multicenter case-control study of the effect of acute rejection and cytomegalovirus infection on pneumocystis pneumonia in solid organ transplant recipients","volume":"68","author":"Hosseini-Moghaddam","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2023.03.005_bib48","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00228-019-02730-0","article-title":"m-TOR inhibitors and risk of Pneumocystis pneumonia after solid organ transplantation: a systematic review and meta-analysis","volume":"75","author":"Ghadimi","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib49","doi-asserted-by":"crossref","first-page":"e12876","DOI":"10.1111\/tid.12876","article-title":"Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation","volume":"20","author":"Werbel","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/tid.12184","article-title":"Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients","volume":"16","author":"Perez-Ordo\u00f1o","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib51","doi-asserted-by":"crossref","first-page":"e12984","DOI":"10.1111\/tid.12984","article-title":"Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort","volume":"20","author":"Neofytos","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/jof1030293","article-title":"Pneumocystis pneumonia in solid-organ transplant recipients","volume":"1","author":"Iriart","year":"2015","journal-title":"Journal of Fungi"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00000441-200101000-00009","article-title":"Pneumocystis carinii pneumonia in patients without HIV infection","volume":"321","author":"Russian","year":"2001","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.idc.2023.03.005_bib54","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1183\/09031936.95.08091548","article-title":"Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients","volume":"8","author":"Ewig","year":"1995","journal-title":"Eur Respir J"},{"issue":"s4","key":"10.1016\/j.idc.2023.03.005_bib55","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12119","article-title":"Practice AIDCo. Pneumocystis pneumonia in solid organ transplantation","volume":"13","author":"Martin","year":"2013","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"10.1016\/j.idc.2023.03.005_bib56","first-page":"S377","article-title":"Human immunodeficiency virus infection and pneumothorax","volume":"6","author":"Terzi","year":"2014","journal-title":"J\u00a0Thorac Dis"},{"issue":"5","key":"10.1016\/j.idc.2023.03.005_bib57","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-100-5-663","article-title":"Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies","volume":"100","author":"Kovacs","year":"1984","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/CMR.10.3.401","article-title":"Extrapulmonary pneumocystosis","volume":"10","author":"Ng","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib59","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1378\/chest.91.3.323","article-title":"Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS","volume":"91","author":"DeLorenzo","year":"1987","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.idc.2023.03.005_bib60","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2214\/ajr.172.5.10227507","article-title":"The changing face of Pneumocystis carinii pneumonia in AIDS patients","volume":"172","author":"Boiselle","year":"1999","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib61","doi-asserted-by":"crossref","first-page":"W555","DOI":"10.2214\/AJR.11.7329","article-title":"Pneumocystis jiroveci pneumonia: high-resolution CT findings in patients with and without HIV infection","volume":"198","author":"Kanne","year":"2012","journal-title":"AJR-American Journal of Roentgenology"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib62","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.ejrad.2011.02.052","article-title":"HRCT-features of Pneumocystis jiroveci pneumonia and their evolution before and after treatment in non-HIV immunocompromised patients","volume":"81","author":"Vogel","year":"2012","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib63","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1164\/rccm.201103-0473IM","article-title":"Reversible cystic lesions of Pneumocystis jirovecii pneumonia","volume":"185","author":"Lu","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib64","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.radcr.2019.03.016","article-title":"High-resolution CT, histopathologic, and clinical features of granulomatous pneumocystis jiroveci pneumonia","volume":"14","author":"Dako","year":"2019","journal-title":"Radiol Case Rep"},{"key":"10.1016\/j.idc.2023.03.005_bib65","series-title":"Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome. Seminars in respiratory infections","year":"1998"},{"issue":"4","key":"10.1016\/j.idc.2023.03.005_bib66","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.79.4.420","article-title":"Pneumocystis infection masquerading as diffuse alveolar damage: a potential source of diagnostic error","volume":"79","author":"Askin","year":"1981","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.idc.2023.03.005_bib67","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/PAS.0b013e3181d9f16a","article-title":"Granulomatous reaction to pneumocystis jirovecii: clinicopathologic review of 20 cases","volume":"34","author":"Hartel","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib68","first-page":"105","article-title":"Role of special stains in the diagnosis of Pneumocystis carinii infection from bronchial washing specimens in patients with the acquired immune deficiency syndrome","volume":"32","author":"Chandra","year":"1988","journal-title":"Acta Cytol"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib69","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/am.27.1.144-149.1974","article-title":"Direct fluorescent-antibody method for the diagnosis of Pneumocystis carinii pneumonitis from sputa or tracheal aspirates from humans","volume":"27","author":"Lim","year":"1974","journal-title":"Appl Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib70","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1093\/cid\/cis412","article-title":"Association between circulating DNA, serum (1->3)-\u03b2-D-glucan, and pulmonary fungal burden in Pneumocystis pneumonia","volume":"55","author":"Costa","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib71","first-page":"36","article-title":"Usefulness of (1,3) \u00df-D-glucan detection in bronchoalveolar lavage samples in Pneumocystis pneumonia and Pneumocystis pulmonary colonization","volume":"25","author":"Damiani","year":"2015","journal-title":"J\u00a0Mycol Med"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1469-0691.2011.03760.x","article-title":"Accuracy of \u03b2-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis","volume":"19","author":"Karageorgopoulos","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib73","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/cdli.3.2.197-199.1996","article-title":"(1-->3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia","volume":"3","author":"Yasuoka","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"issue":"12","key":"10.1016\/j.idc.2023.03.005_bib74","first-page":"2214","article-title":"Diagnosis of pneumocystis pneumonia using serum (1-3)-\u03b2-D-Glucan: a bivariate meta-analysis and systematic review","volume":"7","author":"Li","year":"2015","journal-title":"J\u00a0Thorac Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib75","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","article-title":"Diagnostic accuracy of serum 1, 3-\u03b2-D-glucan for Pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis","volume":"50","author":"Onishi","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2023.03.005_bib76","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jiac.2014.07.001","article-title":"Serum (1\u2192 3) \u03b2-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization","volume":"20","author":"Tasaka","year":"2014","journal-title":"J\u00a0Infect Chemother"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib77","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-0691.2011.03605.x","article-title":"Quantitative real-time PCR and the (1\u2192 3)-\u03b2-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization","volume":"18","author":"Matsumura","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.idc.2023.03.005_bib78","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/s41409-020-0872-y","article-title":"Defibrotide formulations contain (1\u21923)-\u03b2-D-glucan that could influence clinical diagnostic testing","volume":"55","author":"Alosaimy","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.idc.2023.03.005_bib79","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1128\/AAC.00658-06","article-title":"Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials","volume":"50","author":"Marty","year":"2006","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.idc.2023.03.005_bib80","article-title":"False positive serum levels of (1-3)-\u00df-D-Glucan after infusion of intravenous immunoglobulins and time to normalisation","volume":"76","author":"Egger","year":"2017","journal-title":"J\u00a0Infect"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib81","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cid\/ciab1028","article-title":"High false-positive rate of (1,3)-\u03b2-D-Glucan in Onco-hematological patients receiving immunoglobulins and therapeutic antibodies","volume":"75","author":"Tschopp","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2023.03.005_bib82","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/cid\/ciy1072","article-title":"Clinical Performance of (1,3) Beta-D Glucan for the Diagnosis of Pneumocystis Pneumonia (PCP) in Cancer Patients Tested With PCP Polymerase Chain Reaction","volume":"69","author":"Morjaria","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2023.03.005_bib83","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkw156","article-title":"ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Alanio","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.idc.2023.03.005_bib84","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1099\/jmm.0.45528-0","article-title":"Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens","volume":"53","author":"Flori","year":"2004","journal-title":"J\u00a0Med Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib85","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/QCO.0b013e32834cac17","article-title":"Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools","volume":"24","author":"Reid","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib86","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/JCM.02876-15","article-title":"Performances of Four Real-Time PCR Assays for Diagnosis of Pneumocystis jirovecii Pneumonia","volume":"54","author":"Sasso","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib87","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/JCM.03174-15","article-title":"Detection of pneumocystis jirovecii by quantitative PCR to differentiate colonization and pneumonia in immunocompromised HIV-positive and HIV-negative patients","volume":"54","author":"Fauchier","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.idc.2023.03.005_bib88","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1469-0691.2010.03400.x","article-title":"Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients","volume":"17","author":"Alanio","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib89","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/JCM.06036-11","article-title":"Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients","volume":"50","author":"Botterel","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"8","key":"10.1016\/j.idc.2023.03.005_bib90","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/cid\/ciy1072","article-title":"Clinical Performance of (1,3) Beta-D glucan for the diagnosis of pneumocystis pneumonia (PCP) in cancer patients tested with PCP polymerase chain reaction","volume":"69","author":"Morjaria","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2023.03.005_bib91","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/JCM.01554-13","article-title":"Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-\u03b2-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization","volume":"51","author":"Damiani","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib92","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/mmy\/myz115","article-title":"The Fungal PCR Initiative's evaluation of in-house and commercial Pneumocystis jirovecii qPCR assays: Toward a standard for a diagnostics assay","volume":"58","author":"Gits-Muselli","year":"2019","journal-title":"Med Mycol"},{"issue":"5","key":"10.1016\/j.idc.2023.03.005_bib93","doi-asserted-by":"crossref","first-page":"e0010122","DOI":"10.1128\/jcm.00101-22","article-title":"Accuracy of pneumocystis jirovecii plasma cell-free DNA PCR for noninvasive diagnosis of pneumocystis pneumonia","volume":"60","author":"Moreno","year":"2022","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.idc.2023.03.005_bib94","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac652","article-title":"Clinical impact of noninvasive plasma microbial cell-free deoxyribonucleic acid sequencing for the diagnosis and management of pneumocystis jirovecii pneumonia: a single-center retrospective study","volume":"9","author":"Foong","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2023.03.005_bib95","doi-asserted-by":"crossref","first-page":"w13184","DOI":"10.4414\/smw.2011.13184","article-title":"Accuracy of serum LDH elevation for the diagnosis of Pneumocystis jiroveci pneumonia","volume":"141","author":"Vogel","year":"2011","journal-title":"Swiss Med Wkly"},{"issue":"4","key":"10.1016\/j.idc.2023.03.005_bib96","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1378\/chest.95.4.803","article-title":"Elevated levels of angiotensin-converting enzyme in Pneumocystis carinii pneumonia","volume":"95","author":"Singer","year":"1989","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib97","doi-asserted-by":"crossref","first-page":"12508","DOI":"10.1038\/s41598-019-49036-w","article-title":"Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipients","volume":"9","author":"Hamroun","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.idc.2023.03.005_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2014.11.025","article-title":"Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers","volume":"21","author":"Esteves","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2023.03.005_bib99","series-title":"Mandell, douglas, and bennett's principles and practice of infectious diseases E-book","author":"Bennett","year":"2019"},{"issue":"9","key":"10.1016\/j.idc.2023.03.005_bib100","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkw158","article-title":"ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients","volume":"71","author":"Maschmeyer","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.idc.2023.03.005_bib101","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/AAC.36.9.1935","article-title":"Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia","volume":"36","author":"Walzer","year":"1992","journal-title":"Antimicrobial Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib102","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/4.2.608","article-title":"Trimethoprim-sulfamethoxazole in the treatment of adults with pneumonia due to Pneumocystis carinii","volume":"4","author":"Young","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2023.03.005_bib103","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-109-4-280","article-title":"Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study","volume":"109","author":"Sattler","year":"1988","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib104","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00002030-199203000-00007","article-title":"Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial","volume":"6","author":"Klein","year":"1992","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-105-1-37","article-title":"Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial","volume":"105","author":"Wharton","year":"1986","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.idc.2023.03.005_bib106","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-124-9-199605010-00003","volume":"124","author":"Safrin","year":"1996","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib107","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/clinids\/4.2.426","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients","volume":"4","author":"Jick","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib108","article-title":"Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV\/AIDS in patients with previous history of hypersensitivity to cotrimoxazole","author":"Lin","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib109","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1128\/AAC.32.6.807","article-title":"Activity of clindamycin with primaquine against Pneumocystis carinii in\u00a0vitro and in\u00a0vivo","volume":"32","author":"Queener","year":"1988","journal-title":"Antimicrobial Agents Chemother"},{"issue":"12","key":"10.1016\/j.idc.2023.03.005_bib110","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/archinte.161.12.1529","article-title":"A\u00a0meta-analysis of salvage therapy for Pneumocystis carinii pneumonia","volume":"161","author":"Smego","year":"2001","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/QAI.0b013e31816de84d","article-title":"Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review","volume":"48","author":"Benfield","year":"2008","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"21","key":"10.1016\/j.idc.2023.03.005_bib112","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJM199305273282103","article-title":"Comparison of Atovaquone (566C80) with Trimethoprim-Sulfamethoxazole to Treat Pneumocystis carinii Pneumonia in Patients with AIDS","volume":"328","author":"Hughes","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib113","doi-asserted-by":"crossref","first-page":"174","DOI":"10.7326\/0003-4819-121-3-199408010-00003","article-title":"Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group","volume":"121","author":"Dohn","year":"1994","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.idc.2023.03.005_bib114","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1345\/aph.1Q139","article-title":"Dapsone-induced methemoglobinemia: a primer for clinicians","volume":"45","author":"Barclay","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3892\/etm.2015.2929","article-title":"Adjunctive corticosteroids for the treatment of Pneumocystis jiroveci pneumonia in patients with HIV: A meta-analysis","volume":"11","author":"Wang","year":"2016","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib116","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1097\/TXD.0000000000000642","article-title":"A\u00a0Systematic Review and meta-analysis of the data behind current recommendations for corticosteroids in Non-HIV-Related PCP: knowing when you are on shaky foundations","volume":"3","author":"Injean","year":"2017","journal-title":"Transplant Direct"},{"issue":"9","key":"10.1016\/j.idc.2023.03.005_bib117","doi-asserted-by":"crossref","first-page":"e13587","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin Transplant"},{"issue":"21","key":"10.1016\/j.idc.2023.03.005_bib118","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM199011223232131","article-title":"Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome","volume":"323","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib119","doi-asserted-by":"crossref","first-page":"e8524","DOI":"10.1371\/journal.pone.0008524","article-title":"Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection","volume":"5","author":"Cushion","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.idc.2023.03.005_bib120","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/AAC.40.8.1811","article-title":"Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in\u00a0vitro and in\u00a0vivo","volume":"40","author":"Bartlett","year":"1996","journal-title":"Antimicrobial Agents Chemother"},{"issue":"8","key":"10.1016\/j.idc.2023.03.005_bib121","doi-asserted-by":"crossref","first-page":"e70619","DOI":"10.1371\/journal.pone.0070619","article-title":"Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice","volume":"8","author":"Lobo","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.idc.2023.03.005_bib122","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/QAD.0000000000002207","article-title":"Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia","volume":"33","author":"Huang","year":"2019","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib123","doi-asserted-by":"crossref","first-page":"105820","DOI":"10.1016\/j.ijantimicag.2019.10.001","article-title":"Anidulafungin as an alternative treatment for Pneumocystis jirovecii pneumonia in patients who cannot tolerate trimethoprim\/sulfamethoxazole","volume":"55","author":"Chen","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.idc.2023.03.005_bib124","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01296-19","article-title":"Caspofungin and pneumocystis pneumonia: it is time to go ahead","volume":"63","author":"Nevez","year":"2019","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.idc.2023.03.005_bib125","article-title":"SCY-078 demonstrates antifungal activity against Pneumocystis in a prophylactic murine model of Pneumocystis pneumonia","author":"Cushion","year":"2018","journal-title":"ASM Microbe Online"},{"issue":"9","key":"10.1016\/j.idc.2023.03.005_bib126","first-page":"747","article-title":"The long-acting echinocandin, rezafungin, prevents pneumocystis pneumonia and eliminates pneumocystis from the lungs in prophylaxis and murine treatment models","volume":"7","author":"Cushion","year":"2021","journal-title":"J\u00a0Fungi"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib127","doi-asserted-by":"crossref","first-page":"ofaa016","DOI":"10.1093\/ofid\/ofaa016","article-title":"Hope on the horizon: novel fungal treatments in development","volume":"7","author":"Rauseo","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2023.03.005_bib128","doi-asserted-by":"crossref","first-page":"e0238184","DOI":"10.1371\/journal.pone.0238184","article-title":"Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China","volume":"15","author":"Zhu","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.idc.2023.03.005_bib129","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/315824","article-title":"Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene","volume":"182","author":"Huang","year":"2000","journal-title":"J\u00a0Infect Dis"},{"issue":"9281","key":"10.1016\/j.idc.2023.03.005_bib130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(01)05705-1","article-title":"Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study","volume":"358","author":"Navin","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.idc.2023.03.005_bib131","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cid\/ciy154","article-title":"Pneumocystis cytochrome b mutants associated with atovaquone prophylaxis failure as the cause of Pneumocystis infection outbreak among heart transplant recipients","volume":"67","author":"Argy","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2023.03.005_bib132","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/318835","article-title":"Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS","volume":"183","author":"Kazanjian","year":"2001","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2023.03.005_bib133","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01290-16","article-title":"High prevalence of pneumocystis jirovecii dihydropteroate synthase gene mutations in patients with a first episode of pneumocystis pneumonia in santiago, chile, and clinical response to trimethoprim-sulfamethoxazole therapy","volume":"61","author":"Ponce","year":"2017","journal-title":"Antimicrobial Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2023.03.005_bib134","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.idc.2023.03.005_bib135","doi-asserted-by":"crossref","first-page":"e13587","DOI":"10.1111\/ctr.13587","article-title":"Practice tAIDCo. Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.idc.2023.03.005_bib136","doi-asserted-by":"crossref","first-page":"e13511","DOI":"10.1111\/tid.13511","article-title":"Experience with a six-month regimen of Pneumocystis pneumonia prophylaxis in 122 HIV-positive kidney transplant recipients","volume":"23","author":"Mejia","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.03.005_bib137","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12879-019-3944-0","article-title":"Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation","volume":"19","author":"Prasad","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2023.03.005_bib138","doi-asserted-by":"crossref","first-page":"e0052122","DOI":"10.1128\/aac.00521-22","article-title":"The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate)","volume":"66","author":"Wiederhold","year":"2022","journal-title":"Antimicrobial Agents Chemother"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552023000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552023000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:32:35Z","timestamp":1760196755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552023000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":138,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0891552023000260"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2023.03.005","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2023.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}